The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Roche Pharma AG (Inst)
Update of progression-free survival (PFS) and correlative biomarker analysis from coBRIM: Phase III study of cobimetinib (cobi) plus vemurafenib (vem) in advanced BRAF-mutated melanoma.
 
James M. G. Larkin
Research Funding - Novartis (Inst); Pfizer (Inst)
 
Yibing Yan
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
Other Relationship - Roche/Genentech
 
Grant A. McArthur
Honoraria - Provectus
Consulting or Advisory Role - Provectus
Research Funding - Celgene; Millennium; Novartis; Pfizer; Ventana Medical Systems
Patents, Royalties, Other Intellectual Property - Grant McArthur; Grant McArthur
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Millennium; Novartis; Roche Pharma AG
 
Paolo Antonio Ascierto
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche/Genentech; Ventana Medical Systems
Research Funding - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst); Ventana Medical Systems (Inst)
 
Gabriella Liszkay
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Roche Pharma AG (Inst)
 
Michele Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche Pharma AG
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck Sharp & Dohme; Roche Pharma AG
 
Mario Mandalà
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Lev V. Demidov
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); GlaxoSmithKline; GlaxoSmithKline (Inst); Merck Sharp & Dohme; Merck Sharp & Dohme (Inst); Pfizer; Pfizer (Inst); Roche Pharma AG; Roche Pharma AG (Inst)
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Luc Thomas
No Relationships to Disclose
 
Luis De La Cruz-Merino
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG
 
Victoria Atkinson
Honoraria - GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche Pharma AG
 
Caroline Dutriaux
No Relationships to Disclose
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Philogen; Roche Pharma AG
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Philogen; Roche Pharma AG
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Philogen; Roche Pharma AG
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Roche Pharma AG (Inst)
 
Matthew Wongchenko
Employment - Genentech
Stock and Other Ownership Interests - ARIAD; Genentech
 
Isabelle Anne Rooney
No Relationships to Disclose
 
Ilsung Chang
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Patents, Royalties, Other Intellectual Property - Genentech (Inst)
Expert Testimony - Genentech
Travel, Accommodations, Expenses - Genentech
Other Relationship - Genentech
 
Stephen Paul Hack
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Brigitte Dréno
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; Roche Pharma AG
 
Antoni Ribas
Stock and Other Ownership Interests - Compugen; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Merck Sharp & Dohme (Inst)